Virax Biolabs Group (VRAX) Short Interest Ratio & Short Volume $1.00 -0.02 (-1.92%) Closing price 07/23/2025 03:55 PM EasternExtended Trading$1.03 +0.03 (+3.16%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Short Interest DataVirax Biolabs Group (VRAX) has a short interest of 131,000 shares, representing 0.91% of the float (the number of shares available for trading by the public). This marks a 529.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 1.73 million shares to cover all short positions.Current Short Interest131,000 sharesPrevious Short Interest20,800 sharesChange Vs. Previous Month+529.81%Dollar Volume Sold Short$103.71 thousandShort Interest Ratio1.0 Days to CoverLast Record DateJune 30, 2025Outstanding Shares4,340,000 sharesFloat Size14,460,000 sharesShort Percent of Float0.91%Today's Trading Volume89,309 sharesAverage Trading Volume1,727,875 sharesToday's Volume Vs. Average5% Short Selling Virax Biolabs Group? Sign up to receive the latest short interest report for Virax Biolabs Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRAX Short Interest Over TimeVRAX Days to Cover Over TimeVRAX Percentage of Float Shorted Over Time Virax Biolabs Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025131,000 shares $103.71 thousand +529.8%0.9%1 $0.79 6/15/202520,800 shares $18.36 thousand -57.6%0.5%0.2 $0.88 5/31/202549,100 shares $46.65 thousand -55.9%1.2%0.3 $0.95 5/15/2025111,400 shares $118.08 thousand -23.2%2.8%0.6 $1.06 4/30/2025145,100 shares $142.23 thousand -43.9%3.6%0.6 $0.98 4/15/2025258,800 shares $274.33 thousand +85.9%6.4%1.1 $1.06 3/31/2025139,200 shares $158.69 thousand -12.2%3.4%0.6 $1.14 3/15/2025158,600 shares $217.28 thousand -21.7%3.9%0.4 $1.37 2/28/2025202,600 shares $338.34 thousand +12.3%5.0%0.5 $1.67 2/15/2025180,400 shares $343.54 thousand +205.8%4.5%0.5 $1.90 Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 1/31/202559,000 shares $99.71 thousand -45.9%1.5%0.2 $1.69 1/15/2025109,000 shares $225.63 thousand -33.9%2.7%0.1 $2.07 12/31/2024164,900 shares $371.03 thousand +85.5%4.1%0.1 $2.25 12/15/202488,900 shares $139.57 thousand -38.5%2.2%0.1 $1.57 11/30/2024144,600 shares $284.86 thousand -49.1%3.6%0.1 $1.97 11/15/2024284,000 shares $508.36 thousand -36.4%7.0%0.1 $1.79 10/31/2024446,500 shares $924.26 thousand +92.6%11.0%0.1 $2.07 10/15/2024231,800 shares $394.06 thousand -9.2%5.7%0 $1.70 9/30/2024255,300 shares $495.28 thousand +45.4%6.3%0.1 $1.94 9/15/2024175,600 shares $454.80 thousand -72.2%4.3%0 $2.59 8/31/2024632,400 shares $2.95 million +142.7%15.6%0.1 $4.66 8/15/2024260,600 shares $362.23 thousand +1,278.8%12.6%0.1 $1.39 7/31/202418,900 shares $23.53 thousand -54.2%1.1%0 $1.25 7/15/202441,300 shares $46.67 thousand -36.6%2.4%0 $1.13 6/30/202465,100 shares $75.52 thousand -75.6%3.8%0 $1.16 6/15/2024266,800 shares $482.91 thousand +467.7%15.4%0.2 $1.81 5/31/202447,000 shares $55.46 thousand +7,733.3%2.7%0 $1.18 5/15/2024600 shares $476.10 -14.3%0.0%0 $0.79 4/30/2024700 shares $441.00 -94.2%0.0%0 $0.63 4/15/202412,000 shares $8.10 thousand +300.0%0.7%0.2 $0.68 3/31/20243,000 shares $2.15 thousand -80.9%0.2%0 $0.72 3/15/202415,700 shares $13.28 thousand -74.1%1.2%0.1 $0.85 2/29/202460,600 shares $58.33 thousand +9.2%4.6%0.4 $0.96 2/15/202455,500 shares $45.63 thousand -44.8%4.2%0.4 $0.82 1/31/2024100,500 shares $82.41 thousand +233.9%8.5%0.8 $0.82 1/15/202430,100 shares $31.00 thousand -78.3%2.6%0.4 $1.03 12/31/2023138,600 shares $202.36 thousand +6,500.0%7.7%1.9 $1.46 12/15/20232,100 shares $3.33 thousand -93.1%0.0%0 $1.59 11/30/202330,200 shares $7.02 thousand -39.8%0.3%0.2 $0.23 11/15/202350,200 shares $12.75 thousand -30.4%0.5%0.3 $0.25Bitcoin Beats Gold — But This Coin Could Beat Them Both (Ad)Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, who called Bitcoin’s breakout to $100K nearly to the day, says a lesser-known coin could be even bigger. It’s faster, cheaper, and backed by Google, Visa, and top VCs with over $200 million already invested.Get the name of this “third pillar” crypto in Juan’s free report → 10/31/202372,100 shares $17.69 thousand -24.7%0.8%0.4 $0.25 10/15/202395,700 shares $28.33 thousand -24.1%1.0%0.6 $0.30 9/30/2023126,000 shares $40.95 thousand -32.9%1.4%0.7 $0.33 9/15/2023187,800 shares $67.89 thousand +476.1%2.0%1.1 $0.36 8/31/202332,600 shares $11.67 thousand +565.3%0.4%0.1 $0.36 8/15/20234,900 shares $1.89 thousand -80.3%0.1%0 $0.39 7/31/202324,900 shares $9.82 thousand -48.2%0.3%0.1 $0.39 7/15/202348,100 shares $19.20 thousand -68.9%0.5%0.2 $0.40 6/30/2023154,400 shares $60.20 thousand -46.2%1.7%0.3 $0.39 6/15/2023286,700 shares $117.20 thousand +42.2%3.1%0.5 $0.41 5/31/2023201,600 shares $78.97 thousand +0.6%3.2%0.4 $0.39 5/15/2023200,500 shares $70.40 thousand No Change3.1%0.1 $0.35 VRAX Short Interest - Frequently Asked Questions What is Virax Biolabs Group's current short interest? Short interest is the volume of Virax Biolabs Group shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 131,000 shares of VRAX short. 0.91% of Virax Biolabs Group's shares are currently sold short. Learn More on Virax Biolabs Group's current short interest. What is a good short interest ratio for Virax Biolabs Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRAX shares currently have a short interest ratio of 1.0. Learn More on Virax Biolabs Group's short interest ratio. What is a good short interest percentage for Virax Biolabs Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.91% of Virax Biolabs Group's floating shares are currently sold short. Is Virax Biolabs Group's short interest increasing or decreasing? Virax Biolabs Group saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 131,000 shares, an increase of 529.8% from the previous total of 20,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virax Biolabs Group's float size? Virax Biolabs Group currently has issued a total of 4,340,000 shares. Some of Virax Biolabs Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virax Biolabs Group currently has a public float of 14,460,000 shares. How does Virax Biolabs Group's short interest compare to its competitors? 0.91% of Virax Biolabs Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virax Biolabs Group: Lipocine Inc. (2.17%), Hoth Therapeutics, Inc. (4.53%), DURECT Corporation (2.84%), Edesa Biotech, Inc. (0.47%), VYNE Therapeutics Inc. (3.46%), Cyclacel Pharmaceuticals, Inc. (0.08%), Sonnet BioTherapeutics Holdings, Inc. (1.32%), ProPhase Labs, Inc. (2.93%), Carisma Therapeutics Inc. (4.97%), Mannatech, Incorporated (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Virax Biolabs Group stock? Short selling VRAX is an investing strategy that aims to generate trading profit from Virax Biolabs Group as its price is falling. VRAX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virax Biolabs Group? A short squeeze for Virax Biolabs Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRAX, which in turn drives the price of the stock up even further. How often is Virax Biolabs Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRAX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies LPCN Short Interest HOTH Short Interest DRRX Short Interest EDSA Short Interest VYNE Short Interest CYCC Short Interest SONN Short Interest PRPH Short Interest CARM Short Interest MTEX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRAX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.